BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

FDA Approves Johnson & Johnson (JNJ)'s Bluetooth Blood Glucose Monitor


3/5/2013 8:39:19 AM

MILPITAS, Calif., March 4, 2013 /PRNewswire/ -- LifeScan, Inc. announced today that the OneTouch® Verio®Sync Blood Glucose Monitoring System has received clearance from the US Food & Drug Administration (FDA). It is the first meter to automatically send blood glucose results wirelessly via Bluetooth technology to an iPhone, iPad or iPod touch using the OneTouch® Reveal mobile app.

"For so many people, their iPhone, iPad or iPod touch have become a tool of choice to help organize and take charge of their daily lives," said Ty Lee, Vice President of Marketing, representing the products of LifeScan, Inc. & Animas Corp. "For people with diabetes, the new OneTouch® Verio®Sync System will enable them to use their iOS device to view and share their blood glucose results wirelessly, in much the same way they rely on them in other areas of their lives."

Through the OneTouch® Reveal mobile app, users will be able to view a variety of personalized information directly on their iPhone, iPad or iPod touch including a 14-day summary of blood sugar test results, simple visuals showing the percentage of test results within target range, and then share that information via email or text with their care providers, family or friends.

People with diabetes interested in learning more are encouraged to visit www.OneTouch.com where they can sign up to receive email updates on availability and special introductory offers for the OneTouch® Verio®Sync System.

About the Johnson & Johnson Family of Diabetes Companies:
LifeScan, Inc. is one of the five companies that comprise the Johnson & Johnson Family of Diabetes Companies with the shared vision of "Creating a world without limits for people with diabetes." Providing advanced products and services, professional and community education, and advocacy and support to people living with diabetes and their families, these companies include: LifeScan, Inc., (www.OneTouch.com) a world leader in blood glucose monitoring; Animas Corporation, (www.Animas.com) maker of innovative insulin delivery systems; Calibra Medical, Inc., developer of a unique, wearable mealtime only insulin patch; Children with Diabetes, Inc., (www.childrenwithdiabetes.com) a community offering support and education for children, adults and their families living with diabetes; and the Johnson & Johnson Diabetes Institute, LLC, (www.JJDI.com) that empowers healthcare professionals with education and training programs to improve the quality of life for people with diabetes.

iPhone, iPad, and iPod touch are trademarks of Apple Inc., registered in the U.S. and other countries.
The Bluetooth word mark is a registered trademark owned by Bluetooth SIG, Inc. and any use of such marks by LifeScan, Inc. is under license.

SOURCE LifeScan, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES